1 / 4

H igh-gradients for proton therapy KT Fund project – KT Introduction

H igh-gradients for proton therapy KT Fund project – KT Introduction. Enrico Chesta Head of CERN Technology Transfer and Intellectual Property Management Section Knowledge Transfer Group – FP Department. Why?. CERN Impact-driven Innovation Approach. What?.

molimo
Download Presentation

H igh-gradients for proton therapy KT Fund project – KT Introduction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. High-gradients for proton therapy KT Fund project – KT Introduction Enrico Chesta Head of CERN Technology Transfer and IntellectualProperty Management Section Knowledge Transfer Group – FP Department

  2. Why? CERN Impact-driven Innovation Approach

  3. What? Results of 08/12/2012 KT Fund Selection Committee Hardware contribution flexible Collaboration BE-EN “Recirculation mode” option

  4. How? • KT Fund financial support • The KT Fund is a tool introduced 3 years ago, using resources generated by the exploitation of CERN IP portfolio complemented by DG budget, currently supporting 11 projects (6 of which with main applications to medicine/life-science) • Project support given by a TTO from KT (Zoe Lawson): • Project planning and control • Support with IP issues (including patentability and prior art studies) • Help contacting external partners for setting up new collaborations and negotiating contractual conditions if useful • Perform techno-economic assessments of innovative technologies identified during the execution of the project • Some examples of past contributions: ISOLDE-MEDICIS isotopes review, MicoScint project plan, ADAM dosimeter market assessment…

More Related